Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology
Journal of Gynecologic Oncology · 2026 · 37 (2)
DOI: 10.3802/jgo.2026.37.e90 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Ju-Hyun Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Early Detection of Cancer, Human Papillomavirus Viruses, Papillomavirus Infections, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center.
Abstract (Originalsprache)
High-risk human papillomavirus (hrHPV) is a necessary cause of cervical cancer, and hrHPV testing has increasingly been recognized as an effective screening tool that overcomes the limitations of cytology-based screening. However, standardized clinical guidance for the use of hrHPV testing in cervical cancer screening has been limited in Korea, resulting in variability in clinical practice. This consensus-based clinical practice guideline was developed under the auspices of the Korean Society of Gynecologic Oncology through multidisciplinary collaboration involving experts in gynecology, pathology, laboratory medicine, and public health. Relevant domestic and international evidence was systematically reviewed, and input from diverse clinical settings was incorporated through four public hearings. Final recommendations were established through expert consensus. The guideline presents four key recommendations: hrHPV testing may be considered for women aged 25 years or older, with a recommended screening interval of 3 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.
- Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Ansan, Korea.
- Department of Obstetrics and Gynecology, Korea University Guro Hospital, Seoul, Korea.
- Department of Pathology, National Cancer Center, Goyang, Korea.
- Department of Laboratory Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
ORCID-Profile: Ju-Hyun Kim, Seung-Hyuk Shim, Kyung-Jin Min, Jae-Kwan Lee, Chong Woo Yoo, Min-Jung Kwon, Shin-Wha Lee, Jaeman Bae
Förderung
- National Cancer Center
Zitieren
APA
Kim, J. H., Shim, S. H., Min, K. J., Lee, J. K., Yoo, C. W., Kwon, M. J., Lee, S. W., & Bae, J. (2026). Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology. Journal of Gynecologic Oncology, 37(2). https://doi.org/10.3802/jgo.2026.37.e90
Vancouver
Kim JH, Shim SH, Min KJ, Lee JK, Yoo CW, Kwon MJ, et al. Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology. Journal of Gynecologic Oncology. 2026;37(2). doi:10.3802/jgo.2026.37.e90
BibTeX
@article{Kim2026,
author = {Kim, Ju-Hyun and Shim, Seung-Hyuk and Min, Kyung-Jin and Lee, Jae-Kwan and Yoo, Chong Woo and Kwon, Min-Jung and Lee, Shin-Wha and Bae, Jaeman},
title = {Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology},
journal = {Journal of Gynecologic Oncology},
year = {2026},
volume = {37},
number = {2},
doi = {10.3802/jgo.2026.37.e90}
}
EUVIMED